Rare diseases
Investigational molecules
Locations
Back to Poland51 clinical trials in Bytom, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandStudy on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis
PolandStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
PolandLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
PolandA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
PolandStudy on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis
PolandStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
PolandStudy of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment
PolandStudy on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases
PolandStudy comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis
PolandStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on systemic lupus erythematosus treatments, including studies of innovative therapies like litifilimab and ianalumab. Multiple trials are evaluating new approaches to managing psoriatic arthritis and plaque psoriasis.
Studies aim to improve disease management and patient outcomes through targeted therapies.
Innovative research into inflammatory bowel diseases, with particular focus on Crohn's disease and ulcerative colitis treatments. Studies are evaluating novel compounds like obefazimod and NX-13 for therapeutic efficacy.
Trials emphasize both symptom management and disease modification approaches.
Studies addressing knee osteoarthritis and related conditions, including innovative approaches combining weight management with joint health treatments. Research includes evaluation of new immunotherapy options.
Focus on developing treatments that improve mobility and reduce pain.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
